Non Invasive Electrical Impedance Technology (EIT) for Diagnosing Liver Diseases Severity
NCT ID: NCT03492879
Last Updated: 2018-04-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
210 participants
INTERVENTIONAL
2018-05-15
2019-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The second aim is comparing between Liver Ultrasonography and Electrical Impedance Technology (EIT) to quantify the hepatic steatosis grade in patients with Non Alcoholic Fatty Liver Disease (NAFLD) .
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Liver Disease With Elastography Measurements in Patients Undergoing Liver Transplant Surgery
NCT01890460
Electrical Impedance Tomography in Fatty Liver Detection
NCT05189990
Endosonographic Shear Wave Elastography for Liver Stiffness
NCT04533932
Liver Fibrosis Assessment With ShearWave Elastography
NCT02181452
A Study to Evaluate Liver Stiffness With Shear Wave Elastography
NCT05097963
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study will include three groups:
1. Patients with indication for liver biopsy will undergo a routine liver biopsy and also routine liver Ultrasonography, Shear wave elastography and Electrical Impedance Technology (EIT) (70 patients).
2. Patients with chronic liver diseases will undergo routine liver Ultrasonography, Shear wave elastography and Electrical Impedance Technology (EIT) (70 patients).
3. Patients with Non Alcoholic Fatty Liver Disease will undergo routine liver Ultrasonography, Shear wave elastography and quantification of liver steatosis using the Electrical Impedance Technology (EIT) (70 patients).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Biopsy: Routine tests & EIT Technology
The patients will undergo a routine liver biopsy and also routine liver Ultrasonography, Shear wave elastography and Electrical Impedance Technology (EIT).
EIT Technology
Electrical Impedance Technology is a non-invasive imaging method who is being tested for evaluation of liver fibrosis stage
Routine tests & EIT Technology
The patients will undergo a routine liver Ultrasonography, Shear wave elastography and Electrical Impedance Technology (EIT).
EIT Technology
Electrical Impedance Technology is a non-invasive imaging method who is being tested for evaluation of liver fibrosis stage
NASH : Routine tests & EIT Technology
The patients will undergo a routine liver Ultrasonography, Shear wave elastography and quantification of liver steatosis using the Electrical Impedance Technology (EIT).
EIT Technology
Electrical Impedance Technology is a non-invasive imaging method who is being tested for evaluation of liver fibrosis stage
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EIT Technology
Electrical Impedance Technology is a non-invasive imaging method who is being tested for evaluation of liver fibrosis stage
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Prof. Ziv Ben-Ari MD
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Ziv Ben-Ari MD
Head of liver diseases center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ziv Ben-Ari, MD
Role: PRINCIPAL_INVESTIGATOR
Sheba Medical Center
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SHEBA-17-4351-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.